1969
DOI: 10.1016/s0140-6736(69)92093-5
|View full text |Cite
|
Sign up to set email alerts
|

Cardiac Toxicity of Daunorubicin

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

1
41
0
3

Year Published

1971
1971
2016
2016

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 171 publications
(45 citation statements)
references
References 7 publications
1
41
0
3
Order By: Relevance
“…Doxorubicin (DOX) is one of the most active anthracycline antibiotics that has been used for long time in the therapy of many types of human malignancies [1], [2] either alone or combination with other cytocidal agents [3]. Its clinical uses are limited by seriously high incidence of cardiotoxicity, acute effects can occur immediately after treatment and are characterized by transient arrhythmias, reversible hypotension and pericarditis [4] while, chronic cardiotoxicity can manifest years to decades after treatment.…”
Section: Introductionmentioning
confidence: 99%
“…Doxorubicin (DOX) is one of the most active anthracycline antibiotics that has been used for long time in the therapy of many types of human malignancies [1], [2] either alone or combination with other cytocidal agents [3]. Its clinical uses are limited by seriously high incidence of cardiotoxicity, acute effects can occur immediately after treatment and are characterized by transient arrhythmias, reversible hypotension and pericarditis [4] while, chronic cardiotoxicity can manifest years to decades after treatment.…”
Section: Introductionmentioning
confidence: 99%
“…Since their introduction in the 1960s it has been well recognised that anthracyclines cause cardiac toxicity. [3] The anti-neoplastic effect of anthracyclines is achieved via their inhibition of DNA synthesis, transcription and replication, however using iron as a co-factor they also generate reactive oxygen species (ROS) which directly damage protein, lipids and DNA causing oxidative stress. Since cardiomyocytes have lower levels of free radical scavenging systems they are more sensitive to ROS induced injury.…”
Section: Introductionmentioning
confidence: 99%
“…However, it is being recognized that other mechanisms, including the generation of free radical intermediates ( 5 , 6) and possibly bioreductive covalent attachment to biomolecules, may also be significant (7). These agents suffer from two serious disadvantages: ( i ) a tendency to undergo reductive deglycosidation to produce the inactive 7-deoxyaglycones (1,2), and (ii) a severe dose-related cardiotoxicity (8,9). Evidence has accumulated to indicate that both effects require 'Studies related to antitumor antibiotics, Part XXVI.…”
Section: Introductionmentioning
confidence: 99%